Kintara Therapeutics Inc. (KTRA) with a beta value of 1.39 appears to be a promising investment opportunity.

A new trading day began on June 21, 2022, with Kintara Therapeutics Inc. (NASDAQ: KTRA) stock priced at $0.2075, up 18.75% from the previous day of trading. During the day, the shares moved up to $0.26 and dropped to $0.2075 before settling in for the closing price of $0.20. KTRA’s price has ranged from $0.14 to $2.85 over the past 52 weeks.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Meanwhile, its annual earnings per share averaged -83.30%. With a float of $44.79 million, this company’s outstanding shares have now reached $49.13 million.

Let’s determine the extent of company efficiency that accounts for 4 employees.

Kintara Therapeutics Inc. (KTRA) Breakdown of a Key Holders of the stock

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Kintara Therapeutics Inc. is 0.10%, while institutional ownership is 5.70%. The most recent insider transaction that took place on Feb 15, was worth 25,795. In this transaction President and CEO of this company bought 55,000 shares at a rate of $0.47, taking the stock ownership to the 55,000 shares. Before that another transaction happened on Dec 08, when Company’s Chief Financial Officer bought 28,700 for $0.68, making the entire transaction worth $19,430. This insider now owns 37,186 shares in total.

Kintara Therapeutics Inc. (KTRA) Recent Fiscal highlights

In its latest quarterly report, released on 12/30/2021, the company reported earnings of -$0.12 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a return on equity of -706.33. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -83.30% per share during the next fiscal year.

Kintara Therapeutics Inc. (NASDAQ: KTRA) Trading Performance Indicators

Here are Kintara Therapeutics Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.10.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.68, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach 0.03 in one year’s time.

Technical Analysis of Kintara Therapeutics Inc. (KTRA)

Looking closely at Kintara Therapeutics Inc. (NASDAQ: KTRA), its last 5-days average volume was 12.65 million, which is a jump from its year-to-date volume of 2.32 million. As of the previous 9 days, the stock’s Stochastic %D was 37.71%. Additionally, its Average True Range was 0.03.

During the past 100 days, Kintara Therapeutics Inc.’s (KTRA) raw stochastic average was set at 13.85%, which indicates a significant decrease from 62.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 171.90% in the past 14 days, which was higher than the 141.56% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.2296, while its 200-day Moving Average is $0.5598. However, in the short run, Kintara Therapeutics Inc.’s stock first resistance to watch stands at $0.2625. Second resistance stands at $0.2875. The third major resistance level sits at $0.3150. If the price goes on to break the first support level at $0.2100, it is likely to go to the next support level at $0.1825. Now, if the price goes above the second support level, the third support stands at $0.1575.

Kintara Therapeutics Inc. (NASDAQ: KTRA) Key Stats

With a market capitalization of 16.15 million, the company has a total of 65,533K Shares Outstanding. Currently, annual sales are 0 K while annual income is -38,300 K. The company’s previous quarter sales were 0 K while its latest quarter income was -5,360 K.

Latest

Citigroup Upgraded Nokia Oyj (NOK) To Buy with Price Target of $6.8

Nokia Oyj (NYSE: NOK), a communications equipment developer, is...

The Chart for Block Inc. (SQ) Stock Is Flashing Mixed Signals

In the first quarter, large investment funds expanded their...

What to Expect When Snap Inc. (SNAP) Reports Quarterly Earnings?

Snapchat, a social media platform owned by Snap Inc....

Getting Sustainable Earnings? Movado Group Inc. (MOV)

Movado Group Inc. (NYSE: MOV), the owner of the...

Newsletter

 

Don't miss

Chevron Corporation (CVX) provides details about its hydrogen future

The huge hydrogen investment plan of the oil and...

Healthy Upside Potential: Maxar Technologies Ltd. (MAXR)

In May 25 trading, shares of space business Maxar...

Atkore Inc. (ATKR) stock: Better Than You Think

Atkore Inc. (NYSE:ATKR), a manufacturer of infrastructure, electrical, and...

Provention Bio, Inc. (PRVB) Having a Robust Premarket After Abysmal Thursday

Provention Bio, Inc. (PRVB), a clinical stage biopharmaceutical company,...

No matter how cynical the overall market is New Gold Inc. (NGD) performance over the last week is recorded -6.40%

New Gold Inc. (AMEX: NGD) on June 28, 2022, started off the session at the price of $1.26, plunging -5.65% from the previous trading...

$180.21K in average volume shows that Adial Pharmaceuticals Inc. (ADIL) is heading in the right direction

June 28, 2022, Adial Pharmaceuticals Inc. (NASDAQ: ADIL) trading session started at the price of $1.27, that was -8.94% drop from the session before....

$4.33M in average volume shows that Alight Inc. (ALIT) is heading in the right direction

On June 28, 2022, Alight Inc. (NYSE: ALIT) opened at $7.24, lower -5.66% from the last session. During the day, the shares moved up...

LEAVE A REPLY

Please enter your comment!
Please enter your name here


129712

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam